Copy and paste this code to insert a reference to this article in your
blog or online community profile:
 
 
Will Display Like this:
 
Regrowth Concentration Zero (RC0) as Complementary Endpoint Parameter to Evaluate Compound Candidates During Preclinical Drug Development for Cancer Treatment
JCST/Vol.1.1 019-024 (2009). 1:1, (2009)
https://doi.org/10.4172/1948-5956.1000003